New peptide pENW (pGlu-Asn-Trp) inhibits platelet activation by attenuating Akt phosphorylation.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  European Journal of Pharmaceutical Sciences

• Publication date

  2012-04-11

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejps.2011.12.001PMID 22285483
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The roles and mechanisms of PAR4 and P2Y12/phosphatidylinositol 3‐kinase pathway in maintaining thrombin‐induced platelet aggregation

  2010cited by this paper
• Cyclooxygenase‐2 inhibition inhibits PI3K/AKT kinase activity in epithelial ovarian cancer

  2010cited by this paper
• Salvianolic acid A inhibits platelet activation and arterial thrombosis via inhibition of phosphoinositide 3‐kinase

  2010cited by this paper
• A novel anti-platelet aggregation tripeptide from Agkistrodon acutus venom: isolation and characterization.

  2009cited by this paper
• Biochemistry and toxicology of toxins purified from the venom of the snake Bothrops asper.

  2009cited by this paper
• Platelet receptors and signaling in the dynamics of thrombus formation

  2009cited by this paper
• Anticoagulant and antithrombotic activity of a new peptide pENW (pGlu‐Asn‐Trp)

  2009cited by this paper
• Triggers, targets and treatments for thrombosis

  2008cited by this paper
• AKR1C2 and AKR1C3 mediated prostaglandin D2 metabolism augments the PI3K/Akt proliferative signaling pathway in human prostate cancer cells.

  2008cited by this paper
• The role of Akt in the signaling pathway of the glycoprotein Ib-IX induced platelet activation.

  2008cited by this paper
• Src family kinases mediate neutrophil adhesion to adherent platelets.

  2007cited by this paper
• Protease‐activated receptor‐induced Akt activation – regulation and possible function

  2007cited by this paper
• [Antiplatelet therapy after aspirin-induced upper gastrointestinal bleeding].

  2006cited by this paper
• N49 phospholipase A2, a unique subgroup of snake venom group II phospholipase A2.

  2006cited by this paper
• A Phosphoinositide 3-Kinase-AKT-Nitric Oxide-cGMP Signaling Pathway in Stimulating Platelet Secretion and Aggregation*

  2006cited by this paper
• Levels and value of soluble P-selectin following acute myocardial infarction: evaluating the link between soluble P-selectin levels and recruitment of circulating white blood cells and the marker for the rapid diagnosis of chest pain.

  2005cited by this paper
• Stimulatory Roles of Nitric-oxide Synthase 3 and Guanylyl Cyclase in Platelet Activation*

  2005cited by this paper
• Variability in platelet responsiveness to clopidogrel among 544 individuals.

  2005cited by this paper
• Evaluation of anti-platelet aggregatory effects of aspirin, cilostazol and ramatroban on platelet-rich plasma and whole blood

  2004cited by this paper
• Impaired platelet responses to thrombin and collagen in AKT-1-deficient mice.

  2004cited by this paper
• Phosphoinositide 3-kinases and the regulation of platelet function.

  2004cited by this paper
• P‐selectin in haemostasis

  2004cited by this paper
• Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2.

  2004cited by this paper
• Structure, regulation and function of PKB/AKT--a major therapeutic target.

  2004cited by this paper
• A stimulatory role for cGMP-dependent protein kinase in platelet activation.

  2003cited by this paper
• Essential role for phosphoinositide 3-kinase in shear-dependent signaling between platelet glycoprotein Ib/V/IX and integrin alpha(IIb)beta(3).

  2002cited by this paper
• Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events

  2002cited by this paper
• Essential role for phosphoinositide 3-kinase in shear-dependent signaling between platelet glycoprotein Ib/V/IX and integrin αIIbβ3

  2002cited by this paper
• Antithrombotic and thrombolytic activities of Agkisacutacin, a snake venom proteinase, in experimental models.

  2000cited by this paper
• P-Selectin Expression on Platelets Determines Size and Stability of Platelet Aggregates

  2000cited by this paper
• Quantification of platelet activation status by analyzing P-selectin expression.

  2000cited by this paper
• Dual Regulation of Platelet Protein Kinase B*

  2000cited by this paper
• A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation.

  2000cited by this paper
• Purification, characterization and conformational analysis of a haemorrhagin from the venom of Agkistrodon acutus.

  1997cited by this paper
• Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase‐1 and p70 S6 kinase

  1996cited by this paper
• Action of snake venom components on the haemostatic system.

  1993cited by this paper
• Isolation of human platelets and platelet surface membranes.

  1974cited by this paper
• The aggregation of blood platelets

  1963cited by this paper

• Bioactive Peptides from Natural Sources: Biological Functions, Therapeutic Potential and Applications

  2026cites this paper
• Synthesis and Assessment of Antiplatelet and Antithrombotic Activity of 4-Amino-Substituted 5-Oxoproline Amides and Peptides

  2023cites this paper
• Progress of thrombus formation and research on the structure-activity relationship for antithrombotic drugs.

  2021cites this paper
• Secondary Metabolites from the Leather Coral-Derived Fungal Strain Xylaria sp. FM1005 and Their Glycoprotein IIb/IIIa Inhibitory Activity.

  2021cites this paper
• The in vitro bioavailability of anti-platelet peptides in collagen hydrolysate from silver carp (Hypophthalmichthys molitrix) skin.

  2020cites this paper
• A novel di-peptide Met-Glu from collagen hydrolysates inhibits platelet aggregation and thrombus formation via regulation of Gq-mediated signaling.

  2020cites this paper
• Design, synthesis and evaluation of 1,4-benzodioxine derivatives as novel platelet aggregation inhibitors.

  2018cites this paper
• Design, synthesis and evaluation of novel 2-amino-3-(naphth-2-yl)propanoic acid derivatives as potent inhibitors of platelet aggregation.

  2017cites this paper
• Stimulation of nitric oxide production contributes to the antiplatelet and antithrombotic effect of new peptide pENW (pGlu-Asn-Trp).

  2015cites this paper
• Design, synthesis of novel tryptophan derivatives for antiplatelet aggregation activity based on tripeptide pENW (pGlu-Asn-Trp).

  2015cites this paper
• A Novel Direct Factor Xa Inhibitory Peptide with Anti-Platelet Aggregation Activity from Agkistrodon acutus Venom Hydrolysates

  2015cites this paper
• Tripeptide SQL Inhibits Platelet Aggregation and Thrombus Formation by Affecting PI3K/Akt Signaling

  2015cites this paper
• A CAPE analogue as novel antiplatelet agent efficiently inhibits collagen-induced platelet aggregation.

  2014cites this paper